Brian I Carr1, Vito Guerra. 1. Department of Nutritional Carcinogenesis, IRCCS S. de Bellis National Institute for Digestive Diseases, Castellana Grotte, Italy.
Abstract
BACKGROUND: Thrombocytopenia is a cirrhosis surrogate which is associated with hepatocellular carcinoma (HCC) development. AIMS: To compare the clinical characteristics of HCC in the presence and absence of thrombocytopenia. METHODS: The baseline clinical data of a large cohort of randomly presenting, biopsy-proven HCC patients was examined for phenotypic patterns, after organizing the data by tumor size and subdivision into tumor size terciles. RESULTS: Small tumor size tercile I patients had the lowest platelet counts. Patients with higher platelets within each size tercile had the lowest bilirubin and prothrombin time and higher γ-glutamyl transpeptidase (GGTP) and alkaline phosphatase (ALKP) levels. When patients with similar platelet and bilirubin levels were compared, α-fetoprotein, GGTP, and ALKP were significantly increased in patients with larger tumors and in the presence of portal vein thrombus. Large tumor size tercile III patients without thrombocytopenia had larger tumors, higher GGTP and ALKP, and lower bilirubin levels than did patients with thrombocytopenia. CONCLUSIONS: Thrombocytopenia occurred in 40.7% of patients with smaller tumors but only in 11.3% of patients with larger tumors. Patients without thrombocytopenia had elevated GGTP and ALKP and lower bilirubin levels, regardless of tumor size, but they also had larger tumors within the large tumor tercile.
BACKGROUND:Thrombocytopenia is a cirrhosis surrogate which is associated with hepatocellular carcinoma (HCC) development. AIMS: To compare the clinical characteristics of HCC in the presence and absence of thrombocytopenia. METHODS: The baseline clinical data of a large cohort of randomly presenting, biopsy-proven HCCpatients was examined for phenotypic patterns, after organizing the data by tumor size and subdivision into tumor size terciles. RESULTS: Small tumor size tercile I patients had the lowest platelet counts. Patients with higher platelets within each size tercile had the lowest bilirubin and prothrombin time and higher γ-glutamyl transpeptidase (GGTP) and alkaline phosphatase (ALKP) levels. When patients with similar platelet and bilirubin levels were compared, α-fetoprotein, GGTP, and ALKP were significantly increased in patients with larger tumors and in the presence of portal vein thrombus. Large tumor size tercile III patients without thrombocytopenia had larger tumors, higher GGTP and ALKP, and lower bilirubin levels than did patients with thrombocytopenia. CONCLUSIONS:Thrombocytopenia occurred in 40.7% of patients with smaller tumors but only in 11.3% of patients with larger tumors. Patients without thrombocytopenia had elevated GGTP and ALKP and lower bilirubin levels, regardless of tumor size, but they also had larger tumors within the large tumortercile.
Authors: Jean S Campbell; Steven D Hughes; Debra G Gilbertson; Thomas E Palmer; Matthew S Holdren; Aaron C Haran; Melissa M Odell; Renay L Bauer; Hong-Ping Ren; Harald S Haugen; Matthew M Yeh; Nelson Fausto Journal: Proc Natl Acad Sci U S A Date: 2005-02-22 Impact factor: 11.205
Authors: J Gotzmann; A N M Fischer; M Zojer; M Mikula; V Proell; H Huber; M Jechlinger; T Waerner; A Weith; H Beug; W Mikulits Journal: Oncogene Date: 2006-05-25 Impact factor: 9.867
Authors: Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub Journal: N Engl J Med Date: 2008-10-15 Impact factor: 91.245
Authors: S Truant; E Boleslawski; A Duhamel; A-F Bouras; A Louvet; C Febvay; E Leteurtre; G Huet; P Zerbib; S Dharancy; M Hebbar; F-R Pruvot Journal: Eur J Surg Oncol Date: 2012-08-03 Impact factor: 4.424
Authors: F Trevisani; P E D'Intino; P Caraceni; M Pizzo; G F Stefanini; A Mazziotti; G L Grazi; G Gozzetti; G Gasbarrini; M Bernardi Journal: Cancer Date: 1995-05-01 Impact factor: 6.860
Authors: Wan-Li Wang; Xing-Long Zheng; Zhi-Yong Zhang; Ying Zhou; Jie Hao; Gang Tang; Ou Li; Jun-Xi Xiang; Zheng Wu; Bo Wang Journal: Medicine (Baltimore) Date: 2016-07 Impact factor: 1.889
Authors: Jane Margetts; Laura F Ogle; Stephen L Chan; Anthony W H Chan; K C Allen Chan; David Jamieson; Catherine E Willoughby; Derek A Mann; Caroline L Wilson; Derek M Manas; Winnie Yeo; Helen L Reeves Journal: Br J Cancer Date: 2017-11-09 Impact factor: 7.640